192 related articles for article (PubMed ID: 36703085)
1. Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems.
Mehandole A; Walke N; Mahajan S; Aalhate M; Maji I; Gupta U; Mehra NK; Singh PK
AAPS PharmSciTech; 2023 Jan; 24(1):50. PubMed ID: 36703085
[TBL] [Abstract][Full Text] [Related]
2. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in polymer shell oily-core nanocapsules for drug-delivery applications.
AbdElhamid AS; Zayed DG; Heikal L; Khattab SN; Mady OY; El-Gizawy SA; Elzoghby AO
Nanomedicine (Lond); 2021 Aug; 16(18):1613-1625. PubMed ID: 34189946
[TBL] [Abstract][Full Text] [Related]
4. Applications of polymeric nanocapsules in field of drug delivery systems.
Rong X; Xie Y; Hao X; Chen T; Wang Y; Liu Y
Curr Drug Discov Technol; 2011 Sep; 8(3):173-87. PubMed ID: 21644922
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of obtaining in situ nanocapsules through modified self-microemulsifying drug delivery systems. A new manufacturing approach for oral route administration.
Llera-Rojas VG; Del Real L A; Mendoza-Muñoz N; Melgoza-Contreras LM; Quintanar-Guerrero D
Drug Dev Ind Pharm; 2017 Jun; 43(6):925-931. PubMed ID: 28105857
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine.
Park MJ; Balakrishnan P; Yang SG
Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581
[TBL] [Abstract][Full Text] [Related]
7. Active Encapsulation in Biocompatible Nanocapsules.
Wu B; Yang C; Li B; Feng L; Hai M; Zhao CX; Chen D; Liu K; Weitz DA
Small; 2020 Jul; 16(30):e2002716. PubMed ID: 32578400
[TBL] [Abstract][Full Text] [Related]
8. Nanocapsules: An Emerging Drug Delivery System.
Purohit D; Jalwal P; Manchanda D; Saini S; Verma R; Kaushik D; Mittal V; Kumar M; Bhattacharya T; Rahman MH; Dutt R; Pandey P
Recent Pat Nanotechnol; 2023; 17(3):190-207. PubMed ID: 35142273
[TBL] [Abstract][Full Text] [Related]
9. Influence of the surface properties of nanocapsules on their interaction with intestinal barriers.
Santalices I; Torres D; Lozano MV; Arroyo-Jiménez MM; Alonso MJ; Santander-Ortega MJ
Eur J Pharm Biopharm; 2018 Dec; 133():203-213. PubMed ID: 30268595
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
11. Oral nanoparticulate drug delivery systems for the treatment of intestinal bowel disease and colorectal cancer.
Laffleur F; Mayer AH
Expert Opin Drug Deliv; 2023; 20(11):1595-1607. PubMed ID: 38044874
[TBL] [Abstract][Full Text] [Related]
12. Characterization of different functionalized lipidic nanocapsules as potential drug carriers.
Sánchez-Moreno P; Ortega-Vinuesa JL; Martín-Rodríguez A; Boulaiz H; Marchal-Corrales JA; Peula-García JM
Int J Mol Sci; 2012; 13(2):2405-2424. PubMed ID: 22408461
[TBL] [Abstract][Full Text] [Related]
13. Improving drug biological effects by encapsulation into polymeric nanocapsules.
Frank LA; Contri RV; Beck RC; Pohlmann AR; Guterres SS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(5):623-39. PubMed ID: 25641603
[TBL] [Abstract][Full Text] [Related]
14. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Nanocapsules and Lipid-Core Nanocapsules Have Diverse Skin Penetration.
de Brum TL; Fiel LA; Contri RV; Guterres SS; Pohlmann AR
J Nanosci Nanotechnol; 2015 Jan; 15(1):773-80. PubMed ID: 26328441
[TBL] [Abstract][Full Text] [Related]
16. Lipid Nanocapsule: A Novel Approach to Drug Delivery System Formulation Development.
Kumar P; Yadav N; Chaudhary B; Umakanthan S; Chattu VK; Kazmi I; Al-Abbasi FA; Alzarea SI; Afzal O; Altamimi ASA; Gupta G; Gupta MM
Curr Pharm Biotechnol; 2024; 25(3):268-284. PubMed ID: 37231750
[TBL] [Abstract][Full Text] [Related]
17. Trazodone Loaded Lipid Core Poly (ε-caprolactone) Nanocapsules: Development, Characterization and in Vivo Antidepressant Effect Evaluation.
Elhesaisy N; Swidan S
Sci Rep; 2020 Feb; 10(1):1964. PubMed ID: 32029776
[TBL] [Abstract][Full Text] [Related]
18. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.
Khan S; Sharma A; Jain V
Adv Pharm Bull; 2023 Jul; 13(3):446-460. PubMed ID: 37646052
[TBL] [Abstract][Full Text] [Related]
20. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
Erdoğar N; Akkın S; Bilensoy E
Recent Pat Drug Deliv Formul; 2018; 12(4):252-266. PubMed ID: 30674269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
